These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 12113682)

  • 1. [HCV RNA assessment by PCR technique for screening post-transfusion HCV infection among blood donors].
    Xing W; Xu H; Ma R; Zheng H
    Zhonghua Gan Zang Bing Za Zhi; 2002 Jun; 10(3):211-2. PubMed ID: 12113682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleic acid amplification technology screening for hepatitis C virus and human immunodeficiency virus for blood donations.
    Bamaga MS; Bokhari FF; Aboud AM; Al-Malki M; Alenzi FQ
    Saudi Med J; 2006 Jun; 27(6):781-7. PubMed ID: 16758035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a pooling method for routine anti-HCV screening of blood donors to lower the cost burden on blood banks in countries under development.
    García Z; Taylor L; Ruano A; Pavón L; Ayerdis E; Luftig RB; Visoná KA
    J Med Virol; 1996 Jul; 49(3):218-22. PubMed ID: 8818968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four mini-pool HCV RNA screening outside a blood transfusion setting: results of a 2-year prospective study.
    Seme K; Mocilnik T; Fujs K; Babic DZ; Todorović A; Fras-Stefan T; Poljak M
    J Virol Methods; 2007 Mar; 140(1-2):218-21. PubMed ID: 17157928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HCV transmission through blood transfusion: are HCV-RNA titer in donor serum and genotype major determinants of infection outcome?
    Cardoso MS; Koerner K; Epple S; Dengler T; Kerowgan M; Kubanek B
    Beitr Infusionsther Transfusionsmed; 1996; 33():225-30. PubMed ID: 8865947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of blood donations by hepatitis C virus polymerase chain reaction (HCV-PCR) improves safety of blood products by window period reduction.
    Hitzler WE; Runkel S
    Clin Lab; 2001; 47(5-6):219-22. PubMed ID: 11405599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of blood donors for hepatitis C virus RNA with the MagNA Pure-COBAS AmpliScreen method.
    Palomäki P; Wessberg S; Tuomi K; Laitinen H
    Transfusion; 2005 Sep; 45(9):1518-22. PubMed ID: 16131386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
    Ahmad N; Asgher M; Shafique M; Qureshi JA
    Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and screening costs of hepatitis C virus among Ugandan blood donors.
    Hladik W; Kataaha P; Mermin J; Purdy M; Otekat G; Lackritz E; Alter MJ; Downing R
    Trop Med Int Health; 2006 Jun; 11(6):951-4. PubMed ID: 16772018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experiences in HCV-NAT screening prior to releasing cellular components by the German Red Cross Blood Transfusion Service of Baden-Württemberg.
    Cardoso MS; Koerner K; Hinz W; Lenz C; Prokein S; Rau B; Schwandt A; Kubanek B
    Biologicals; 1999 Dec; 27(4):281-4. PubMed ID: 10686053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatitis C virus genotype and subtype frequency in hepatitis C virus RNA-positive, hepatitis C virus antibody-negative blood donors identified in the nucleic acid test screening program in Poland.
    Brojer E; Gronowska A; Medyńska J; Grabarczyk P; Mikulska M; Letowska M; Kryczka W; Gietka A
    Transfusion; 2004 Dec; 44(12):1706-10. PubMed ID: 15584984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and genotypes of hepatitis C virus infection among drug addicts and blood donors in Thailand.
    Verachai V; Phutiprawan T; Theamboonlers A; Chinchai T; Tanprasert S; Haagmans BL; Osterhaus AD; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):849-51. PubMed ID: 12757237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
    Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
    Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors.
    Busch MP; Glynn SA; Stramer SL; Orland J; Murphy EL; Wright DJ; Kleinman S;
    Transfusion; 2006 Mar; 46(3):469-75. PubMed ID: 16533292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early prediction of hepatitis C virus (HCV) infection relapse in nonresponders to primary interferon therapy by means of HCV RNA whole-blood analysis.
    Watkins-Riedel T; Ferenci P; Steindl-Munda P; Gschwantler M; Mueller C; Woegerbauer M
    Clin Infect Dis; 2004 Dec; 39(12):1754-60. PubMed ID: 15578395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening of serologically negative plasma pools for hepatitis C virus by nucleic acid amplification testing in Croatia, 2001-2003.
    Forcić D; Zgorelec R; Kosutić-Gulija T; Ivancić J; Baricević M; Lupret L; Mazuran R
    Transfus Apher Sci; 2005 Oct; 33(2):175-9. PubMed ID: 16122985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing?
    Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y
    Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003].
    Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M;
    Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of NucliSens-AmpliScreen methodology to detect subtypes G of HIV-1 and 4c/4d of HCV in the screening of blood donors.
    Araújo F; Henriques I; Monteiro F; Meireles E; Cruz A; Tavares G; Mota-Miranda A
    Transfus Clin Biol; 2005 Oct; 12(4):331-5. PubMed ID: 16182583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.